Mann J R
Centre for Early Human Development, Monash University, Clayton, Victoria, Australia.
Biol Reprod. 1988 Jun;38(5):1077-83. doi: 10.1095/biolreprod38.5.1077.
A mature motile mouse spermatozoon was microinjected under the zona pellucida of mouse eggs. Twenty-five percent of eggs were fertilized, and 54% of these developed to normal fetuses or to term after transfer to pseudopregnant recipients. These results provide a quantitative estimate of the minimum proportion of spermatozoa in a population that are able to contribute to normal development--at least 54% of mature individuals that were able to fertilize the egg after microinjection, or at least 13 1/2% (25% of 54%) of the total population of mature sperm. The production of normal young shows that sperm microinjection is a feasible means for the treatment of severe male infertility in the human and in other species.
将一枚成熟可游动的小鼠精子显微注射到小鼠卵子的透明带下。25%的卵子受精,其中54%在移植到假孕受体后发育成正常胎儿或足月产。这些结果提供了对能够促进正常发育的精子群体最小比例的定量估计——至少54%的成熟个体在显微注射后能够使卵子受精,或者至少占成熟精子总数的13.5%(54%的25%)。正常幼崽的产生表明,精子显微注射是治疗人类和其他物种严重男性不育的一种可行方法。